Home NDC 42291-080 Ezetimibe and Simvastatin
Product NDC 42291-080
11-digit product format 422910080
Labeler code 42291
Product ID 42291-080_ea379ef9-ddc8-ef34-e053-2995a90a6db3
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Ezetimibe and Simvastatin
Dosage form TABLET
Route ORAL
Labeler AvKARE
Application ANDA208831
Marketing category ANDA
Marketing start 2022-10-04
Marketing end 0000-00-00
Substance EZETIMIBE; SIMVASTATIN
Active strength 10 mg/1; mg/1
Pharmacologic classes Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A208831-001 EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN 10MG;10MG TABLET / ORAL 2017-11-21 A208831-002 EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN 10MG;20MG TABLET / ORAL 2017-11-21 A208831-003 EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN 10MG;40MG TABLET / ORAL 2017-11-21 A208831-004 EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN 10MG;80MG TABLET / ORAL 2017-11-21
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 5 of 5 · 180 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A208831-001 EZETIMIBE AND SIMVASTATIN 10MG;10MG TABLET / ORAL AB 2017-11-21 3a93d1ddd44b…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A208831-002 EZETIMIBE AND SIMVASTATIN 10MG;20MG TABLET / ORAL AB 2017-11-21 3a93d1ddd44b…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A208831-003 EZETIMIBE AND SIMVASTATIN 10MG;40MG TABLET / ORAL AB 2017-11-21 3a93d1ddd44b…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A208831-004 EZETIMIBE AND SIMVASTATIN 10MG;80MG TABLET / ORAL AB 2017-11-21 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 A208831-001 EZETIMIBE AND SIMVASTATIN 10MG;10MG TABLET / ORAL AB 2017-11-21 f41ea6bd6efb…2022-10-28 04:53 UTC 2022-10 A208831-002 EZETIMIBE AND SIMVASTATIN 10MG;20MG TABLET / ORAL AB 2017-11-21 f41ea6bd6efb…2022-10-28 04:53 UTC 2022-10 A208831-003 EZETIMIBE AND SIMVASTATIN 10MG;40MG TABLET / ORAL AB 2017-11-21 f41ea6bd6efb…2022-10-28 04:53 UTC 2022-10 A208831-004 EZETIMIBE AND SIMVASTATIN 10MG;80MG TABLET / ORAL AB 2017-11-21 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 A208831-001 EZETIMIBE AND SIMVASTATIN 10MG;10MG TABLET / ORAL AB 2017-11-21 e64feba35796…2022-09-29 23:25 UTC 2022-09 A208831-002 EZETIMIBE AND SIMVASTATIN 10MG;20MG TABLET / ORAL AB 2017-11-21 e64feba35796…2022-09-29 23:25 UTC 2022-09 A208831-003 EZETIMIBE AND SIMVASTATIN 10MG;40MG TABLET / ORAL AB 2017-11-21 e64feba35796…2022-09-29 23:25 UTC 2022-09 A208831-004 EZETIMIBE AND SIMVASTATIN 10MG;80MG TABLET / ORAL AB 2017-11-21 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A208831-001 EZETIMIBE AND SIMVASTATIN 10MG;10MG TABLET / ORAL AB 2017-11-21 cb3db0bc1861…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A208831-002 EZETIMIBE AND SIMVASTATIN 10MG;20MG TABLET / ORAL AB 2017-11-21 cb3db0bc1861…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A208831-003 EZETIMIBE AND SIMVASTATIN 10MG;40MG TABLET / ORAL AB 2017-11-21 cb3db0bc1861…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A208831-004 EZETIMIBE AND SIMVASTATIN 10MG;80MG TABLET / ORAL AB 2017-11-21 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A208831-001 EZETIMIBE AND SIMVASTATIN 10MG;10MG TABLET / ORAL 2017-11-21 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A208831-002 EZETIMIBE AND SIMVASTATIN 10MG;20MG TABLET / ORAL 2017-11-21 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A208831-003 EZETIMIBE AND SIMVASTATIN 10MG;40MG TABLET / ORAL 2017-11-21 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A208831-004 EZETIMIBE AND SIMVASTATIN 10MG;80MG TABLET / ORAL 2017-11-21 a50c72e98297…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 4 · 148 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts# DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 42291-080 EZETIMIBE AND SIMVASTATIN TABLET [AVKARE] 2 Legacy NDC 20240110_ea37adb0-a162-42d9-e053-2995a90aeaad.zip
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 42291-080-10 42291008010 1000 TABLET in 1 BOTTLE (42291-080-10) 1000 tablet 2022-10-04 0000-00-00 No No Current